Author:
Zhu Xu,Guo Jun,He Cancan,Geng Huaxiao,Yu Gengsheng,Li Jinqing,Zheng Hairong,Ji Xiaojuan,Yan Fei
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Poon, M., Badimon, J. J. & Fuster, V. Viewpoint Overcoming restenosis with sirolimus: from alphabet soup to clinical reality. Lancet 359, 619–622 (2002).
2. Yadav, J. et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. New Engl.J. Med. 351, 1493–1501 (2004).
3. Costa, M. A. & Simon, D. I. Molecular basis of restenosis and drug-eluting stents. Circulation 111, 2257–2273 (2005).
4. Ialenti, A. et al. Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries. Arterioscl. Throm.Vas. 31, 2448–2454 (2011).
5. Katsanos, K. et al. Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials. Cardiovasc. Inter. Rad. 36, 645–658 (2013).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献